Literature DB >> 34580106

ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation.

Akiko Arakawa1, Emma Reeves2, Sigrid Vollmer3, Yukiyasu Arakawa3, Mengwen He3, Adrian Galinski3, Julia Stöhr3, Klaus Dornmair4, Edward James2, Jörg C Prinz1.   

Abstract

Autoimmune diseases develop when autoantigens activate previously quiescent self-reactive lymphocytes. Gene-gene interaction between certain HLA class I risk alleles and variants of the endoplasmic reticulum aminopeptidase ERAP1 controls the risk for common immune-mediated diseases, including psoriasis, ankylosing spondylitis, and Behçet disease. The functional mechanisms underlying this statistical association are unknown. In psoriasis, HLA-C*06:02 mediates an autoimmune response against melanocytes by autoantigen presentation. Using various genetically modified cell lines together with an autoreactive psoriatic TCR in a TCR activation assay, we demonstrate in this study that in psoriasis, ERAP1 generates the causative melanocyte autoantigen through trimming N-terminal elongated peptide precursors to the appropriate length for presentation by HLA-C*06:02. An ERAP1 risk haplotype for psoriasis produced the autoantigen much more efficiently and increased HLA-C expression and stimulation of the psoriatic TCR by melanocytes significantly more than a protective haplotype. Compared with the overall HLA class I molecules, cell surface expression of HLA-C decreased significantly more upon ERAP1 knockout. The combined upregulation of ERAP1 and HLA-C on melanocytes in psoriasis lesions emphasizes the pathogenic relevance of their interaction in patients. We conclude that in psoriasis pathogenesis, the increased generation of an ERAP1-dependent autoantigen by an ERAP1 risk haplotype enhances the likelihood that autoantigen presentation by HLA-C*06:02 will exceed the threshold for activation of potentially autoreactive T cells, thereby triggering CD8+ T cell-mediated autoimmune disease. These data identify ERAP1 function as a central checkpoint and promising therapeutic target in psoriasis and possibly other HLA class I-associated diseases with a similar genetic predisposition.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34580106      PMCID: PMC7611875          DOI: 10.4049/jimmunol.2100686

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

2.  A large-scale screen for coding variants predisposing to psoriasis.

Authors:  Huayang Tang; Xin Jin; Yang Li; Hui Jiang; Xianfa Tang; Xu Yang; Hui Cheng; Ying Qiu; Gang Chen; Junpu Mei; Fusheng Zhou; Renhua Wu; Xianbo Zuo; Yong Zhang; Xiaodong Zheng; Qi Cai; Xianyong Yin; Cheng Quan; Haojing Shao; Yong Cui; Fangzhen Tian; Xia Zhao; Hong Liu; Fengli Xiao; Fengping Xu; Jianwen Han; Dongmei Shi; Anping Zhang; Cheng Zhou; Qibin Li; Xing Fan; Liya Lin; Hongqing Tian; Zaixing Wang; Huiling Fu; Fang Wang; Baoqi Yang; Shaowei Huang; Bo Liang; Xuefeng Xie; Yunqing Ren; Qingquan Gu; Guangdong Wen; Yulin Sun; Xueli Wu; Lin Dang; Min Xia; Junjun Shan; Tianhang Li; Lin Yang; Xiuyun Zhang; Yuzhen Li; Chundi He; Aie Xu; Liping Wei; Xiaohang Zhao; Xinghua Gao; Jinhua Xu; Furen Zhang; Jianzhong Zhang; Yingrui Li; Liangdan Sun; Jianjun Liu; Runsheng Chen; Sen Yang; Jun Wang; Xuejun Zhang
Journal:  Nat Genet       Date:  2013-11-10       Impact factor: 38.330

3.  The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.

Authors:  Gianna Elena Hammer; Federico Gonzalez; Marine Champsaur; Dragana Cado; Nilabh Shastri
Journal:  Nat Immunol       Date:  2005-11-20       Impact factor: 25.606

4.  Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide.

Authors:  A Craiu; T Akopian; A Goldberg; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.

Authors:  Rajan P Nair; Philip E Stuart; Ioana Nistor; Ravi Hiremagalore; Nicholas V C Chia; Stefan Jenisch; Michael Weichenthal; Gonçalo R Abecasis; Henry W Lim; Enno Christophers; John J Voorhees; James T Elder
Journal:  Am J Hum Genet       Date:  2006-03-31       Impact factor: 11.025

6.  CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes.

Authors:  J C Chang; L R Smith; K J Froning; B J Schwabe; J A Laxer; L L Caralli; H H Kurland; M A Karasek; D I Wilkinson; D J Carlo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides.

Authors:  Tomo Saric; Shih-Chung Chang; Akira Hattori; Ian A York; Shirley Markant; Kenneth L Rock; Masafumi Tsujimoto; Alfred L Goldberg
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

8.  Unopposed IL-36 Activity Promotes Clonal CD4+ T-Cell Responses with IL-17A Production in Generalized Pustular Psoriasis.

Authors:  Akiko Arakawa; Sigrid Vollmer; Petra Besgen; Adrian Galinski; Burkhard Summer; Yoshio Kawakami; Andreas Wollenberg; Klaus Dornmair; Michael Spannagl; Thomas Ruzicka; Peter Thomas; Jörg C Prinz
Journal:  J Invest Dermatol       Date:  2017-12-27       Impact factor: 8.551

9.  The proteomics of N-terminal methionine cleavage.

Authors:  Frédéric Frottin; Aude Martinez; Philippe Peynot; Sanghamitra Mitra; Richard C Holz; Carmela Giglione; Thierry Meinnel
Journal:  Mol Cell Proteomics       Date:  2006-09-08       Impact factor: 5.911

10.  Structural and regulatory diversity shape HLA-C protein expression levels.

Authors:  Gurman Kaur; Stephanie Gras; Jesse I Mobbs; Julian P Vivian; Adrian Cortes; Thomas Barber; Subita Balaram Kuttikkatte; Lise Torp Jensen; Kathrine E Attfield; Calliope A Dendrou; Mary Carrington; Gil McVean; Anthony W Purcell; Jamie Rossjohn; Lars Fugger
Journal:  Nat Commun       Date:  2017-06-26       Impact factor: 14.919

View more
  2 in total

1.  Data Mining and Meta-Analysis of Psoriasis Based on Association Rules.

Authors:  Jiarui Ou; Jianglin Zhang
Journal:  J Healthc Eng       Date:  2022-01-27       Impact factor: 2.682

2.  ERAP2 Inhibition Induces Cell-Surface Presentation by MOLT-4 Leukemia Cancer Cells of Many Novel and Potentially Antigenic Peptides.

Authors:  Ioannis Temponeras; George Stamatakis; Martina Samiotaki; Dimitris Georgiadis; Harris Pratsinis; George Panayotou; Efstratios Stratikos
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.